167 related articles for article (PubMed ID: 20713348)
1. Thyroid function and 3,3'-diiodothyronine sulfate cross-reactive substance (compound W) in maternal hyperthyroidism with antithyroid treatment.
Vanmiddlesworth L; Vanmiddlesworth NR; Egerman RS; Bush AJ; Ramsey RD; Delmar LP; Ho EC; Wu SY
Endocr Pract; 2011; 17(2):170-6. PubMed ID: 20713348
[TBL] [Abstract][Full Text] [Related]
2. Compound W, a 3,3'-diiodothyronine sulfate cross-reactive substance in serum from pregnant women--a potential marker for fetal thyroid function.
Wu SY; Huang WS; Ho E; Wu ES; Fisher DA
Pediatr Res; 2007 Mar; 61(3):307-12. PubMed ID: 17314688
[TBL] [Abstract][Full Text] [Related]
3. Maternal compound W serial measurements for the management of fetal hypothyroidsm.
Cortelazzi D; Morpurgo PS; Zamperini P; Fisher DA; Beck-Peccoz P; Wu SY
Eur J Endocrinol; 1999 Dec; 141(6):570-8. PubMed ID: 10601958
[TBL] [Abstract][Full Text] [Related]
4. Fetal free thyroxine concentrations in pregnant women with autoimmune thyroid disease.
Spremovic-Radjenovic S; Gudovic A; Lazovic G; Marinkovic J; Radunovic N; Ljubic A
J Clin Endocrinol Metab; 2012 Nov; 97(11):4014-21. PubMed ID: 22948761
[TBL] [Abstract][Full Text] [Related]
5. [Effects of maternal hyperthyroidism and antithyroid drug therapy on thyroid function of newborn infants].
Lian XL; Bai Y; Xun YH; Dai WX; Guo ZS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Dec; 27(6):756-60. PubMed ID: 16447653
[TBL] [Abstract][Full Text] [Related]
6. A 3,3'-diiodothyronine sulfate cross-reactive compound in serum from pregnant women.
Wu SY; Polk DH; Chen WL; Fisher DA; Huang WS; Yee B
J Clin Endocrinol Metab; 1994 Jun; 78(6):1505-9. PubMed ID: 8200954
[TBL] [Abstract][Full Text] [Related]
7. Prediction of neonatal hyperthyroidism in infants born to mothers with Graves disease.
Skuza KA; Sills IN; Stene M; Rapaport R
J Pediatr; 1996 Feb; 128(2):264-8. PubMed ID: 8636826
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for neonatal thyroid dysfunction in pregnancies complicated by Graves' disease.
Uenaka M; Tanimura K; Tairaku S; Morioka I; Ebina Y; Yamada H
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():89-93. PubMed ID: 24726178
[TBL] [Abstract][Full Text] [Related]
9. A T2S cross-reactive material (compound W) in hyperthyroid patients with trophoblastic disease.
Rajatanavin R; Fisher DA; Chailurkit L; Huang WS; Srisupandit S; Wu SY
Thyroid; 1999 Oct; 9(10):989-94. PubMed ID: 10560952
[TBL] [Abstract][Full Text] [Related]
10. Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol.
Nachum Z; Rakover Y; Weiner E; Shalev E
Am J Obstet Gynecol; 2003 Jul; 189(1):159-65. PubMed ID: 12861156
[TBL] [Abstract][Full Text] [Related]
11. Management of hyperthyroidism during pregnancy and lactation.
Azizi F; Amouzegar A
Eur J Endocrinol; 2011 Jun; 164(6):871-6. PubMed ID: 21389085
[TBL] [Abstract][Full Text] [Related]
12. Thyroid function and intellectual development of infants nursed by mothers taking methimazole.
Azizi F; Khoshniat M; Bahrainian M; Hedayati M
J Clin Endocrinol Metab; 2000 Sep; 85(9):3233-8. PubMed ID: 10999814
[TBL] [Abstract][Full Text] [Related]
13. Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis.
Mandel SJ; Brent GA; Larsen PR
Thyroid; 1994; 4(1):129-33. PubMed ID: 7519913
[TBL] [Abstract][Full Text] [Related]
14. Drug therapy for hyperthyroidism in pregnancy: safety issues for mother and fetus.
Atkins P; Cohen SB; Phillips BJ
Drug Saf; 2000 Sep; 23(3):229-44. PubMed ID: 11005705
[TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of 3, 3'-diiodothyronine, 3', 5'-diiodothyronine, and 3, 5-diiodothyronine in altered thyroid states.
Nishikawa M; Inada M; Naito K; Ishii H; Tanaka K; Mashio Y; Imura H
Endocrinol Jpn; 1983 Apr; 30(2):167-72. PubMed ID: 6641638
[TBL] [Abstract][Full Text] [Related]
16. [Effects of maternal hyperthyroidism and antithyroid drug therapy on congenital malformation of newborn infants].
Lian XL; Bai Y; Xu YH; Dai WX; Guo ZS
Zhonghua Fu Chan Ke Za Zhi; 2005 Aug; 40(8):511-5. PubMed ID: 16202286
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations of adiponectin in patients with hyperthyroidism before and after control of thyroid function.
Hsieh CJ; Wang PW
Endocr J; 2008 Jul; 55(3):489-94. PubMed ID: 18469483
[TBL] [Abstract][Full Text] [Related]
18. Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study.
Chen CH; Xirasagar S; Lin CC; Wang LH; Kou YR; Lin HC
BJOG; 2011 Oct; 118(11):1365-73. PubMed ID: 21624036
[TBL] [Abstract][Full Text] [Related]
19. Twin pregnancy with a coexisting hydatiform mole and liveborn infant: complicated by maternal hyperthyroidism and neonatal hypothyroidism.
True DK; Thomsett M; Liley H; Chitturi S; Cincotta R; Morton A; Cotterill A
J Paediatr Child Health; 2007 Sep; 43(9):646-8. PubMed ID: 17688651
[TBL] [Abstract][Full Text] [Related]
20. Urinary compound W in pregnant women is a potential marker for fetal thyroid function.
Wu SY; Fisher DA; Huang WS; Beck-Peccoz P; Emerson CH; Kuo SW; Chen WL
Am J Obstet Gynecol; 1998 May; 178(5):886-91. PubMed ID: 9609555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
